Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Ting Liu

Showing results (41-50 of 123) with videos related to

Pageof 13
Sort By:
BMC Cancer|December 10, 2021
Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinomaLi-Ting Liu, Shan-Shan Guo, Hui Li, et al.
BMC Cancer|November 4, 2022
Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissectionSai-Lan Liu, Xiao-Yun Li, Xue-Song Sun, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 1, 2025
Endoplasmic reticulum-localized circular RNA FAM13B restrains nasopharyngeal carcinoma lymphatic metastasis through downregulating XBP1Guo-Dong Jia, Si-Yi Xie, Xiao-Yun Li, et al.
BMC Cancer|October 2, 2024
Comparison of long-term quality of life and their predictors in survivors between paediatric and adult nasopharyngeal carcinoma in the intensity-modulated radiotherapy eraJing Jin, Shan-Shan Guo, Li-Ting Liu, et al.
Cancer Medicine|October 9, 2020
Identifying optimal candidates for induction chemotherapy among stage II-IVa nasopharyngeal carcinoma based on pretreatment Epstein-Barr virus DNA and nodal maximal standard uptake values of [<sup>18</sup> F]-fluorodeoxyglucose positron emission tomographyHao-Jun Xie, Yi-Fei Yu, Xue-Song Sun, et al.
Radiation Oncology (London, England)|November 27, 2014
The impact of smoking on the clinical outcome of locoregionally advanced nasopharyngeal carcinoma after chemoradiotherapyShan-Shan Guo, Pei-Yu Huang, Qiu-Yan Chen, et al.
Oral Oncology|April 24, 2019
Effect of local treatment for metastasis and its sequence with chemotherapy on prognosis of post-treatment metastatic nasopharyngeal carcinoma patientsYu-Jing Liang, Xue-Song Sun, Zhen-Chong Yang, et al.
Cancer Research and Treatment|January 16, 2018
Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort AnalysisYang Li, Lin-Quan Tang, Li-Ting Liu, et al.
NPJ Precision Oncology|December 2, 2025
Who may omit locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a failure-pattern-based strategy in the immunotherapy eraJia-Rui He, Yu-Xi Xiao, Lin-Fang Wu, et al.
Plos One|April 9, 2015
Different prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrenceTing Shen, Lin-Quan Tang, Dong-Hua Luo, et al.
Pageof 13

Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
BMC Cancer|December 10, 2021
Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinomaLi-Ting Liu, Shan-Shan Guo, Hui Li, et al.
BMC Cancer|November 4, 2022
Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissectionSai-Lan Liu, Xiao-Yun Li, Xue-Song Sun, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 1, 2025
Endoplasmic reticulum-localized circular RNA FAM13B restrains nasopharyngeal carcinoma lymphatic metastasis through downregulating XBP1Guo-Dong Jia, Si-Yi Xie, Xiao-Yun Li, et al.
BMC Cancer|October 2, 2024
Comparison of long-term quality of life and their predictors in survivors between paediatric and adult nasopharyngeal carcinoma in the intensity-modulated radiotherapy eraJing Jin, Shan-Shan Guo, Li-Ting Liu, et al.
Cancer Medicine|October 9, 2020
Identifying optimal candidates for induction chemotherapy among stage II-IVa nasopharyngeal carcinoma based on pretreatment Epstein-Barr virus DNA and nodal maximal standard uptake values of [<sup>18</sup> F]-fluorodeoxyglucose positron emission tomographyHao-Jun Xie, Yi-Fei Yu, Xue-Song Sun, et al.
Radiation Oncology (London, England)|November 27, 2014
The impact of smoking on the clinical outcome of locoregionally advanced nasopharyngeal carcinoma after chemoradiotherapyShan-Shan Guo, Pei-Yu Huang, Qiu-Yan Chen, et al.
Oral Oncology|April 24, 2019
Effect of local treatment for metastasis and its sequence with chemotherapy on prognosis of post-treatment metastatic nasopharyngeal carcinoma patientsYu-Jing Liang, Xue-Song Sun, Zhen-Chong Yang, et al.
Cancer Research and Treatment|January 16, 2018
Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort AnalysisYang Li, Lin-Quan Tang, Li-Ting Liu, et al.
NPJ Precision Oncology|December 2, 2025
Who may omit locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a failure-pattern-based strategy in the immunotherapy eraJia-Rui He, Yu-Xi Xiao, Lin-Fang Wu, et al.
Plos One|April 9, 2015
Different prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrenceTing Shen, Lin-Quan Tang, Dong-Hua Luo, et al.
Pageof 13